Infinity to Present at Deutsche Bank Securities’ 2012 dbAccess Biofest Business Wire CAMBRIDGE, Mass. -- November 26, 2012 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 2012 dbAccess Biofest on December 3, 2012 at 1:40 p.m. ET in Boston. A live webcast of this Infinity presentation will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event. About Infinity Pharmaceuticals, Inc. Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company’s website at www.infi.com. Contact: Infinity Pharmaceuticals, Inc. Kate Murray, 617-453-1179 Kate.Murray@infi.com http://www.infi.com
Infinity to Present at Deutsche Bank Securities’ 2012 dbAccess Biofest
Press spacebar to pause and continue. Press esc to stop.